The present study provides evidence that lentivirus-mediated KLF8 knockdown inhibits growth and invasion in osteosarcoma cells, suggesting that KLF8 may be a potential therapeutic biomarker for osteosarcoma. The gene discussed is KLF8; the disease is osteosarcoma.